APP and Alzheimer disease: This molecular alteration strongly contributes to the behavioral and electrophysiological phenotype of the J20 model [54, 124] and has also been identified in other lines of APP transgenic mice, including APP/PS1 and TgCRND8 mice [13, 152], as well as in humans with AD [54].